Estradiol delivery methods compared: How the five options differ

Introduction: One hormone, several delivery routes

Estradiol is the form of estrogen most often used in hormone replacement therapy (HRT). But how estradiol is delivered to the body matters as much as the hormone itself: different routes produce different patterns in the blood, carry different considerations, and suit different situations.

Luvo's Hormone Replacement Program includes several estradiol formulations. This is an educational overview of how each route works and the factors a provider weighs when helping you choose. It's not a recommendation or a promise of a specific result.

Systemic routes: Whole-body delivery

Three estradiol formulations deliver the hormone throughout the body, where it can reach estrogen receptors in multiple tissues.

• Oral tablets are taken once daily and absorbed through the digestive tract, then processed by the liver first (first-pass metabolism). This hepatic step is the defining feature of oral estrogen and is relevant to how a provider assesses clotting-related considerations, since oral estrogen is associated with a higher risk of venous blood clots than transdermal routes.
• Transdermal cream is applied to the skin daily and absorbed directly into the bloodstream, bypassing that first-pass liver step. Because it avoids hepatic processing, it isn't associated with the same increase in clotting factors as oral delivery, which is one reason a provider may consider it for people with certain risk factors. It also allows flexible dose adjustment.
• Transdermal patches are applied to the skin and changed once or twice weekly. Like cream, they deliver estradiol through the skin, and they provide steady levels without daily peaks and troughs. The trade-offs are occasional skin irritation and adhesion in humid conditions.

Local routes: Vaginal and urogenital delivery

Two formulations deliver estradiol directly to vaginal and urogenital tissue, with minimal absorption into the wider circulation.

Vaginal gel is applied with an applicator and distributes across the vaginal walls. Vaginal tablets are inserted and dissolve in place. Both are used for genitourinary symptoms of menopause (GSM), such as vaginal dryness and discomfort, and both keep systemic estradiol levels low, typically within the normal postmenopausal range, which is why they may be appropriate for some people who prefer to limit systemic exposure. Whether either is right for you is a clinical decision.

Using more than one formulation

Some people use a systemic formulation and a vaginal formulation together: a systemic route for whole-body symptoms and a local route for concentrated urogenital relief. This is a common approach because systemic estradiol doesn't always fully address vaginal symptoms. Your clinician designs any combination around your specific situation, and it can be adjusted over time.

How the choice is made

There's no single best route; the right one depends on your health history, your risk factors, your symptoms, and your preferences. A licensed clinician reviews these with you and recommends an approach. Because switching between formulations is straightforward, the initial choice isn't permanent.

Explore Luvo's Hormone Replacement Program to discuss the options with a provider.